CPAP Is Failing Patients With OCD–Vivos Exposes the Hidden Mental Health Risk

Vivos Therapeutics highlights the overlooked link between Obstructive Sleep Apnea (OSA) and mental health disorders like OCD and depression. With CPAP intolerance common among these patients, Vivos offers non-invasive, root-cause treatments that improve sleep quality and support mental well-being—redefining how airway health is integrated into holistic care.

LITTLETON, Colo., July 10, 2025 /PRNewswire-PRWeb/ — Mental health disorders like Obsessive-Compulsive Disorder (OCD) and depression are often fueled by chronic insomnia and disrupted sleep—conditions now known to be closely tied to Obstructive Sleep Apnea (OSA). Individuals with OCD are seven times more likely to experience insomnia, and nearly half report significant sleep-related issues, including undiagnosed OSA. (1) Fatigue, difficulty concentrating, and restless nights are common symptoms that often overlap with undiagnosed sleep apnea. (2) These overlapping signals point to the importance of open dialogue between patients and primary care providers (PCPs), and a greater understanding of how sleep disorders may drive mental health challenges.

Vivos Therapeutics, a leader in airway and sleep health, is at the forefront of educating patients and healthcare professionals about these complex, often overlooked connections. “Sleep is the foundation of whole-person health. It’s not just a symptom,” says Kirk Huntsman, Chairman and CEO of Vivos Therapeutics. “That’s why we call it the sixth vital sign. Without it, even the best treatment plans fall short.”

The Missing Link in Mental Health Treatment
Obstructive Sleep Apnea is more than a nighttime nuisance—it’s a silent disruptor of neurological and emotional balance, closely tied to anxiety, depression, and OCD symptoms. When left untreated, OSA can exacerbate these conditions, creating a cycle that further undermines mental wellness.

Despite these clear connections, traditional OSA treatments like CPAP therapy often fall short—especially for those navigating mental health challenges. Claustrophobia, anxiety, and sensory sensitivity lead to low adherence rates, with compliance estimated at just 12%. (3,4) The result: patients are left with a treatment they can’t tolerate and symptoms that continue to spiral.

Raising awareness among mental health professionals about the interplay between psychiatric disorders and OSA is essential. Greater understanding encourages collaboration with sleep specialists and ensures patients receive integrated care. For those who cannot tolerate CPAP, Vivos offers a scientifically backed, non-invasive alternative.

The Vivos Method uses custom oral appliances to target the root cause of OSA by promoting proper airway development. In most cases, patients complete treatment in under 12 months—no masks, no machines, and no lifelong therapy required.

“By addressing both sleep and mental health together, we can empower patients to break free from the cycle of OSA and regain control over their well-being,” says Huntsman.

Rewriting the Future of Airway Therapy
Vivos’ proprietary treatment methods are redefining what’s possible in sleep and mental health care. Here’s how:

Non-Invasive Treatment: Vivos oral devices offer a comfort-first solution, eliminating the noise, maintenance, and restrictions of CPAP.
Collaborative Care: Integrated screening and airway assessments promote coordination between PCPs, mental health professionals, and sleep specialists.
Root Cause Resolution: Unlike symptom-masking approaches, Vivos addresses the anatomical source of OSA—unlocking long-term improvements in sleep and emotional health.

With more than 60,000 patients treated and a satisfaction rate exceeding 90%, the Vivos Method is a transformative force in sleep medicine.

“OCD symptoms, depression, insomnia, and OSA are not isolated struggles,” stresses Huntsman. “Sleep apnea treatment can be life-changing—empowering patients to reclaim their mental and physical health in ways previously thought impossible.”

Bridging the Gap Between Sleep and Mental Health
Vivos isn’t just a leader in innovative OSA treatments—they are disruptors and educators on a mission to bridge the gap between sleep and mental health. By highlighting the critical connection between sleep apnea and mental well-being, Vivos is reshaping the healthcare landscape with a more holistic approach to patient care.

“Integration is key. We have to stop viewing mental health and physical health as separate entities. They are interconnected, and addressing these overlaps can be nothing short of transformational,” Huntsman asserts.

About VIVOS THERAPEUTICS
Obstructive sleep apnea (OSA) affects over 1 billion people worldwide, yet 90% remain undiagnosed and unaware of their condition. This chronic disorder is not just a sleep issue—it’s closely linked to nearly every modern chronic health condition. While the medical community has made strides in treating sleep disorders, breathing and sleep health remain areas that are still not fully understood. As a result, solutions are often mechanistic and fail to address the root causes of OSA.

Vivos Therapeutics, founded in 2016 and based in Littleton, CO, is changing this. Through innovative technology, education, and partnerships with dentists, functional medicine doctors, and sleep specialists, Vivos is empowering healthcare providers to more thoroughly address the complex needs of patients. Their groundbreaking device is the only FDA 510(k) cleared technology for treating severe OSA and the first to receive clearance for treating moderate to severe OSA in children.

The Vivos Method offers a unique, clinically effective solution that is nonsurgical, noninvasive, and nonpharmaceutical, providing hope for patients with mild to severe OSA. Vivos: Breathe New Life. For more information, visit

References

Fernández de la Cruz, Lorena, et al. “Morbidity and Mortality in Obsessive-Compulsive Disorder: A Narrative Review.” Neuroscience & Biobehavioral Reviews, vol. 136, May 2022, p. 104602, doi.org/10.1016/j.neubiorev.2022.104602.
Vanek, Jakub, et al. “Obstructive Sleep Apnea, Depression and Cognitive Impairment.” Sleep Medicine, vol. 72, Aug. 2020, pp. 50–58, doi.org/10.1016/j.sleep.2020.03.017.
Vivos Therapeutics. “Trapped in CPAP Dependency? Vivos Liberates OSA Patients with Non-Invasive Solution.” Prweb.com, 29 Jan. 2025, prweb.com/releases/trapped-in-cpap-dependency-vivos-liberates-osa-patients-with-non-invasive-solution-302363006.html.
Watenpaugh, Donald. “”CPAP Intolerance” Is a Sweeping, Misused Phrase.” Sleep Review, 9 May 2023, sleepreviewmag.com/sleep-treatments/therapy-devices/cpap-pap-devices/cpap-intolerance-misused-phrase/.